In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease
暂无分享,去创建一个
Jane S. Paulsen | D P Salmon | D. Salmon | C. Fennema-Notestine | T. Jernigan | A. Gamst | J. Corey-Bloom | S. Archibald | G. Peavy | M. Jacobson | S L Archibald | C Fennema-Notestine | T L Jernigan | M W Jacobson | J Corey-Bloom | J S Paulsen | G M Peavy | A C Gamst | J M Hamilton | J. Hamilton
[1] G. M. Halliday,et al. Regional Specificity of Brain Atrophy in Huntington's Disease , 1998, Experimental Neurology.
[2] A. Dale,et al. Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.
[3] R. S. Williams,et al. Morphometric analysis of the prefrontal cortex in Huntington's disease , 1991, Neurology.
[4] Nahida Matta,et al. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain , 1995, Neuron.
[5] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[6] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[7] M. Wasay,et al. Cerebral White Matter Changes (Leukoaraiosis), Stroke, and Gait Disturbance , 1997, Journal of the American Geriatrics Society.
[8] O. Paulson,et al. Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[9] G. Pearlson,et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease , 1997, Neurology.
[10] Terry L. Jernigan,et al. Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases , 1991, Biological Psychiatry.
[11] J. Lowe,et al. The cortical neuritic pathology of Huntington's disease , 1995, Neuropathology and applied neurobiology.
[12] A. Young,et al. A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.
[13] D. Mann,et al. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy , 2004, Acta Neuropathologica.
[14] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[15] J. Penney,et al. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. , 1999, Journal of neuropathology and experimental neurology.
[16] J. Heinrich,et al. Nocturnal TSH Surge and TRH Test Response in the Evaluation of Thyroid Axis in Hypothalamic Pituitary Disorders in Childhood , 1998, Hormone Research in Paediatrics.
[17] J. Vonsattel,et al. Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.
[18] R. Hichwa,et al. PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline , 1986, Annals of neurology.
[19] D. Sax,et al. Evidence of cortical metabolic dysfunction in early Huntington's disease by single‐photon‐emission computed tomography , 1996, Movement disorders : official journal of the Movement Disorder Society.
[20] W. Martin,et al. Cortical glucose metabolism in Huntington's disease , 1992, Neurology.
[21] J. Penney,et al. Huntingtin localization in brains of normal and Huntington's disease patients , 1997, Annals of neurology.
[22] Hitoshi Takahashi,et al. A quantitative investigation of the substantia nigra in Huntington's disease , 1989, Annals of neurology.
[23] H. Herzog,et al. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. , 1990, Brain : a journal of neurology.
[24] D. Eidelberg,et al. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[26] G. Pearlson,et al. Frontal lobe volume in patients with Huntington's disease , 1998, Neurology.
[27] C. Fennema-Notestine,et al. Effects of age on tissues and regions of the cerebrum and cerebellum , 2001, Neurobiology of Aging.
[28] R. Terry,et al. STUDIES ON BRAIN BIOPSIES OF PATIENTS WITH HUNTINGTON'S CHOREA , 1974, Journal of neuropathology and experimental neurology.
[29] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[30] G D Pearlson,et al. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. , 1996, Archives of neurology.
[31] R H Myers,et al. Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus , 1991, Journal of neuropathology and experimental neurology.
[32] G. Bruyn,et al. Pathogenesis of Huntington's chorea. , 1973, Lancet.
[33] D. Salmon,et al. Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. , 1996, Archives of neurology.
[34] N Makris,et al. Evidence for more widespread cerebral pathology in early HD , 2003, Neurology.
[35] P G Bhide,et al. Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain , 2001, Journal of neuropathology and experimental neurology.